Taiwanese Dermatological Association Consensus for the Prevention and Management of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Related Skin Toxicities

March 2017 in “ Journal of the Formosan Medical Association ”

Chia‐Yu Chu, Kuan‐Yu Chen, John Wen‐Cheng Chang, Yufeng Wei, Chih‐Hung Lee, Weiming Wang

epidermal growth factor receptor tyrosine kinase inhibitors EGFR-TKIs acneiform rash xeroderma pruritus paronychia stomatitis mucositis hair changes EGFR inhibitors skin rash dry skin itching nail infection mouth sores inflammation of mucous membranes hair loss

TLDR The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

The 2016 consensus of the Taiwanese Dermatological Association (TDA) provided comprehensive guidelines for preventing and managing skin toxicities caused by epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). The guidelines addressed six major skin toxicities, including acneiform rash, xeroderma, pruritus, paronychia, stomatitis, mucositis, and hair changes, with specific definitions, onset times, grading, care suggestions, and treatment algorithms for each. The recommendations aimed to improve the quality of life for patients undergoing EGFR-TKI treatment by preventing treatment interruptions due to severe skin toxicities. The consensus was supported by 100% of the 15 experts in attendance.

View this study on sciencedirect.com →

Discuss this study in the Community →

Research cited in this study

1 / 1 results

research Dermatologic Adverse Events Associated With Afatinib: An Oral ErbB Family Blocker

87 citations, March 2013 in “Expert Review of Anticancer Therapy”

Afatinib often causes skin problems that need proactive management.

Related Community Posts Join

6 / 54 results

community The Real Cause Of Androgenetic Alopecia

in Research/Science 667 upvotes 1 month ago

Androgenetic alopecia is caused by DHT affecting hair growth. Finasteride and minoxidil are used to manage hair loss by blocking DHT and promoting hair growth.

community New and Interesting HairLoss Studies/Papers/Reviews

in Treatment 44 upvotes 4 years ago

Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

community How all hormones affect our hair follicles. Not just DHT. Take a look at this paper. Prolactin, melatonin, cortisol, progesterone, testosterone and more

in Research/Science 126 upvotes 2 years ago

The conversation discusses various factors affecting hair loss, not just DHT, and mentions treatments like Minoxidil, finasteride, and melatonin. Some users report personal experiences with these treatments and hormone tests, while others speculate on the role of hormones like prolactin and cortisol in hair loss.

community Diffuse hair loss and scalp biopsies

in Research 692 upvotes 3 months ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community A meta analysis of 18 popular hair loss treatments. An 2022 guide on efficacy. From finasteride and minoxidil to caffeine shampoo, saw palmetto and biotin. 96 Scientific References included.

in Research/Science 101 upvotes 2 years ago

Most hair loss treatments are ineffective; only finasteride, dutasteride, and minoxidil show effectiveness.

community So we have 20k dollars human like machines available but no new effective treatment for hairloss since finasteride :)

in Chat 237 upvotes 1 month ago

There have been no new effective hair loss treatments since finasteride, despite technological advancements. Current treatments include finasteride, minoxidil, and RU58841, with ongoing challenges and potential future solutions in research.

Related Research

1 / 1 results

research The Management of EGFR Inhibitor Adverse Events: A Case Series and Treatment Paradigm

32 citations, January 2012 in “International Journal of Dermatology”

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.